Chemotherapy for Advanced Gastric Cancer: Slow but Further Progress

참고문헌 (28)

1. "2002 annual report of the Korea Central Cancer Registry based on registered data from 139 hospitals", 36, pp.103~14 (2004)
2. "Cancer statistics,2000", 50, pp.7~33 (2000)
3. "Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer", 8, pp.163~8 (1997)
4. "Randomised comparison of fluorouracil plus supportive care with supportive care alone inpatients with non-resectable gastric cancer", 71, pp.587~91 (1995)
5. "Modified therapy with 5-fluorouracil and methotrexate in advanced gastric cancer", pp.37~41 (1993)
6. "Standard chemotherapy for gastric carcinoma: Is it a myth?", 18, pp.4001~3 (2000)
7. "A review of chemotherapy in gastric cancer", 34, pp.1576~86 (1974)
8. "Randomized phase III trial of fluorouracil alone versus fluorouracil plus cisplatin versus uracil and tegafur plus mitomycinin patients with unresectable, advanced gastric cancer:The Japan Clinical Oncology Group Study (JCOG9205).", 21, pp.54~9 (2003)
9. "phase III randomized study of 5-fluorouracil and cisplatin versus 5-fluorouracil,doxorubicin,and mitomycin C versus 5-fluorouracil alone in the treatment of advanced gastric cancer", 71, pp.3813~8 (1993)
10. "A less toxic regimen of 5-fluorouracil and high-dose folinic acid for advanced gastrointestinal adenocarcinomas", 64, pp.603~5 (1991)
11. "5-fluorouracil bolus and continuous infusion in poor-prognosis patients with advanced measurable gastric cancer", pp.229~30 (1991)
12. "J Clin Oncol", 5, pp.1150~6 (1987)
13. "Phase II-III chemotherapy studies in advanced gastric cancer"
14. "Chemotherapy of gastric cancer", 15, pp.257~77 (1988)
15. "Phase II study of Taxol in patients with advanced gastric carcinoma", 4, pp.269~74 (1998)
16. "Phase II study of paclitaxel in pretreated advanced gastric cancer", 9, pp.307~10 (1998)
17. "An early phase II study of a 3-hour infusion of paclitaxel for advanced gastric cancer", 21, pp.416~9 (1998)
18. "Phase II trial of docetaxel (Taxotere) in patients with adenocarcinoma of the upper gastrointestinal tract previously untreated with cytotoxic chemotherapy: the EasternCooperative Oncology Group (ECOG) results of protocol E1293.", 13, pp.87~93 (1996)
19. "A late phase II clinical study of RP56976 (docetaxel) in patients with advanced or recurrent gastric cancer: a cooperative study group trial (group B).", 26, pp.487~96 (1999)
20. "Late phase II clinical study of RP56976 (docetaxel) in patients with advanced", recurrent gastric cancer: a JapaneseCooperative Study Group trial (group A)., 1998, pp.25, 1915~24
21. "Docetaxel 75 mg", m(2) is active and well tolerated in patients with metastatic or recurrent gastric cancer: a phase II trial., 2002, pp.32, 248~54
22. "Comparison of topoisomerase I inhibition and cytotoxicity of camptothecin derivatives presently in clinical trials", pp.836~42 (1994)
23. "Arrest of replication forks by drug-stabilized topoisomerase I-DNA cleavable complexes as a mechanism of cell killing by camptothecin", 49, pp.5077~82 (1989)
24. "Irinotecan is active in chemonaive patients with metastatic gastric cancer:a phase II multicentric trial", 89, pp.997~1001 (2003)
25. "A phase II trial of irinotecan in patients with advanced adenocarcinoma of the gastroesophageal (GE) junction.", 19(1130), pp.289~ (2000)
26. "Late phase II study of irinotecan hydrochloride", pp.1033~11 8 (1994)
27. "Report on nationwide pooled data and cohort investigation in UFT phase II study", 22, pp.333~8 (1988)
28. "Phase II trial of Oral UFT and leucovorin in advanced gastric carcinoma", 19, pp.212~6 (1996)

관련 논문AI추천